B&G Foods, Inc.

BGS
About the company

B&G Foods, Inc. manufactures, sells, and distributes a portfolio of shelf-stable and frozen foods, and household products in the United States, Canada, and Puerto Rico. It operates through Specialty, Meals, Frozen & Vegetables, and Spices & Flavor Solutions segments.

Country: United StatesPrice: $3.50Market Cap: $284.0M

Investment snapshot

18%positive consensus
Scored 1d ago

Positive

3

BUY / PASS

Neutral / negative

1 / 12

NEUTRAL / FAIL

Median fair value

$7.31

+108.9% vs price

Models with upside

4 / 17

Positive margin of safety

Strongest signal

9 of 10 pass — Buffett objects

Key risk

No clean pass — all 12 investors flag at least one debt & leverage criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictPASSFAILFAILFAIL · Rank #1616 (Top 52.2%)PASSFAILFAILNEUTRALFAILFAILFAILPASSFAILFAILFAILFAILFAIL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/A-525.0%N/AN/A+61.1%N/A+78.2%+51.2%+52.1%N/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-10-03 · Balance sheet at 2026-10-03 · Annual history · FY 2025

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-03

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-10-03 · TTM ended 2026-10-03 vs 2025-09-27 · TTM ended 2026-10-03

Latest source filing: 2026-11-10

Score computed: 2026-11-14

TTM ended 2026-10-03

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-03

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-10-03 · Balance sheet at 2026-10-03 · Market data at 2026-11-01

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-10-03 · Balance sheet at 2026-10-03

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-03

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-10-03 · Balance sheet at 2026-10-03

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-03

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-10-03 · Balance sheet at 2026-10-03 · Market data at 2026-11-01

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-10-03

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-03

Score computed: 2026-11-14

TTM ended 2026-10-03 · Balance sheet at 2026-10-03 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-10-03

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-10-03

Latest source filing: 2026-11-10

Score computed: 2026-11-14

TTM ended 2026-10-03 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Where It Passes

  • Cash Flow90% pass✓ 11✗ 1▾

    9 of 10 pass — Buffett objects

    Free Cash Flow Proxy$-7.7M
    ✗BuffettPositive and growing
    FCF Positive and Growing$99.5M
    ✓LynchPositive and growing
    Operating Cash Flow$101.4M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=3.58%, ROA=-1.53%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)2.8x
    ✓Dreman< 8x
    P/E or FCF YieldFCF Yield=24.9%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive15/17 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap35.5%
    ✓Ackman>= 4%
    Price / FCF per Share4.0x
    ✓Ackman<= 25
    Positive Operating Cash Flow frequency25/25 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$99.5M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+35.03%; #162/4519 (top 3.6%)
    ✓OshaughnessyTop 10% of eligible cross-section
  • Valuation models80% pass✓ 4✗ 1▾

    Models split on BGS at $3.50 — fair values range $0.56–$16.09

    Greenblatt fair value$0.56
    ✗Greenblatt-525.0% margin vs $3.50
    Munger fair value$8.99
    ✓Munger+61.1% margin vs $3.50
    Akre fair value$16.09
    ✓Akre+78.2% margin vs $3.50
    Marks fair value$7.17
    ✓Marks+51.2% margin vs $3.50
    Ackman fair value$7.31
    ✓Ackman+52.1% margin vs $3.50

Where It Falls Short

  • Debt & Leverage0% pass✓ 2✗ 13▾

    No clean pass — all 12 investors flag at least one debt & leverage criterion

    LT Debt vs Net Current AssetsLT Debt $2.0B vs NCA $501.0M
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 4.31, IC: 0.7x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity5.75
    ✗Lynch< 0.33
    Cash - Long-term Debt$-2.0B
    ✗LynchPositive preferred
    LT Debt / Total Assets Change67.29% -> 68.63%
    ✗PiotroskiDecreased YoY
    Current Assets / Current Liabilities2.84
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity5.75
    ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
    Debt Levels5.75
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=0.7x, D/EBITDA=11.9x
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity5.75
    ✗Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-5.7519; #4090/4210 (top 97.1%)
    ✗AsnessTop 30% of eligible cross-section
  • Profitability6% pass✓ 5✗ 30▾

    15 of 16 flag BGS's profitability — Graham, Buffett, Lynch +12 more

    Positive EPS (10 years)15/26 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)20/26 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-11.9%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)5.3% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$-7.7M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)1.69
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-23.7%
    ✗Lynch> 15%
    EBIT / Enterprise Value2.9%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=2.9%, ROC=9.9%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-1.53%
    ✗PiotroskiROA > 0
    ROA Change YoY-8.39% -> -1.53% (delta: +6.87%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=3.58%, ROA=-1.53%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY21.8% -> 21.8%
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue-4.8%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-23.7%
    ✗Dreman> 12%
    Margin of SafetyP/B=0.6x
    ✓PabraiP/B < 1.5 or P/E < 15
    Return on Equity-21.8% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency20/24 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue3.7%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-23.7%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend3.9% (2023) -> 5.3% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 22.1% -> 21.8%, operating margin 3.9% -> 5.3%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-29.65%; #4797/6340 (top 75.7%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+13.62%; #2519/3702 (top 68.0%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity-23.75%; #3770/5226 (top 72.1%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0341; #2073/5884 (top 35.2%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR-10.0% over 5 years
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years6/10 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Growth13% pass✓ 2✗ 11▾

    7 of 8 flag BGS's growth — Graham, Lynch, Dreman +4 more

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: -12.6% vs Rev: -2.7%
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction$0.98 (2006) -> $-0.54 (2025)
    ✗DremanPositive over recent years
    EPS CAGR0.3% CAGR over 15 years
    ✗Dreman> 5% annualized
    Positive Net Income Frequency20/24 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth-5.4%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency1/5 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 22.1% -> 21.8%, operating margin 3.9% -> 5.3%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR-1.5%
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR-10.0% over 5 years
    ✗Neff7%-20% annualized
  • Valuation15% pass✓ 11✗ 17▾

    11 of 13 flag BGS's valuation — Graham, Lynch, Greenblatt +8 more

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio0.6x
    ✓Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value2.9%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=2.9%, ROC=9.9%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)2.8x
    ✓Dreman< 8x
    Price / Book Value per Share0.6x
    ✓Dreman< 1.2x✓Templeton< 1.5x✓SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessOE Yield=-2.7%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=24.9%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=0.6x
    ✓MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share4.0x
    ✓Ackman<= 25
    Price vs. Trailing Low151% of trailing low ($2.32)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-29.65%; #4797/6340 (top 75.7%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+1.2488; #1146/6449 (top 17.8%)
    ✓AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per ShareN/A (non-positive TBVPS)
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change-56.0%
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+6.3084; #450/5247 (top 8.6%)
    ✓OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+35.03%; #162/4519 (top 3.6%)
    ✓OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-35.42%; #4644/6202 (top 74.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Verdicts19% pass✓ 3✗ 13▾

    Split decision: 12 FAIL · 3 PASS · 1 NEUTRAL

    Overall verdict
    ✓GrahamPASS (4/9)✗BuffettFAIL (0/9)✗LynchFAIL (2/7)✗GreenblattRank #1616✓PiotroskiPASS (F-Score 4)✗DremanFAIL (4/11)✗MungerFAIL (1/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (1/6)✗MarksFAIL (3/5)✗AckmanFAIL (3/9)✓TempletonPASS (4/8)✗SleepFAIL (2/6)✗AsnessFAIL (Rank #1980/2370 (Top 83.5%))✗NeffFAIL (2/6)✗SchlossFAIL (3/7)✗OshaughnessyFAIL (Rank #338/963 (Top 35.1%))
  • Efficiency25% pass✓ 3✗ 8▾

    6 of 8 flag BGS's efficiency — Buffett, Greenblatt, Piotroski +3 more

    Current Ratio2.84
    ✓Graham>= 2.0
    ROIC (3-5 yr avg)1.4%
    ✗Buffett> 10%
    ROIC - WACC-8.6%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)9.9%
    ✗Greenblatt> 25%
    Current Ratio Change YoY3.30 -> 3.32
    ✓PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.65x -> 0.65x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities2.84
    ✓Dreman> 1.5
    Return on Invested Capital2.2%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=2.2%; FY2024: ROIC=-5.5%; FY2025: ROIC=3.2%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest 3.2%)
    ✗SleepROIC > 12% in a majority of years

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Food Products
Size: Micro Cap($284.0M)
Revenue: $1.8B-5.4% YoY
Net Income: $43.3M+82.8% YoY

Financial Snapshot

Operating Margin5.3%
Return on Equity-9.6%
Debt / Equity4.31
Current Ratio3.32
EPS (Diluted)$-0.54
Shares Retired−1.1% / −1.7% 2y

Similar Companies

MDLZMondelez International, Inc.
$85.5B
ADMArcher-Daniels-Midland Co
$34.7B
TSNTYSON FOODS, INC.
$20.7B
GISGENERAL MILLS INC
$18.4B

Shareholder Return

Fiscal 2025

Issued 1.1% of shares last year, 1.7% issued over two.

Buybacks
—
Dividends
$60.6M

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-10-03

2025-09-28 – 2026-10-03

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, operating cash flow, depreciation amortization, capex, dividends paid.

Q3 FY 2026

2026-07-05 – 2026-10-03

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, dividends paid.

Q2 FY 2026

2026-04-05 – 2026-07-04

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, dividends paid.

Q1 FY 2026

2026-01-04 – 2026-04-04

Sources
FY 2025
Sources
  • 10-K · 2026-03-03
FY 2024
Sources
  • 10-K · 2025-02-25
FY 2023
Sources
  • 10-K · 2024-02-28
FY 2022
Sources
  • 10-K · 2023-02-28
FY 2021
Sources
  • 10-K · 2022-03-01
Market Cap$284.0Mcurrent------$336.5Mest.$421.0Mest.$594.2Mest.$708.5Mest.$1.4Best.
Revenue$1.8B↓3%$459.8M↑5%$383.3M↓10%$408.9M↓4%$1.8B↓5%$1.9B↓6%$2.1B↓5%$2.2B↑5%$2.1B
Operating Income$66.1M↑135%$14.2M↑29%$34.6M↑57%-$11.0M↓131%$97.1M↑155%-$177.3M↓320%$80.4M↓18%$98.6M↓50%$196.1M
Net Income-$84.2M↑66%-$32.5M↓70%-$4.0M↑59%-$32.5M↓3997%-$43.3M↑83%-$251.3M↓280%-$66.2M↓482%-$11.4M↓117%$67.4M
EPS (Diluted)--$-0.40↓67%$-0.05↑58%$-0.41↓4200%$-0.54↑83%$-3.18↓257%$-0.89↓456%$-0.16↓116%$1.02
Gross Margin21.8%↑2%23.7%↑5%20.8%↑1%19.5%↓8%21.8%21.8%↓1%22.1%↑17%18.9%↓11%21.3%
Operating Margin3.7%↑136%3.1%↑23%9.0%↑74%-2.7%↓132%5.3%↑158%-9.2%↓335%3.9%↓14%4.6%↓52%9.5%
ROE-23.7%↑55%———-9.6%↑80%-47.9%↓504%-7.9%↓505%-1.3%↓118%7.3%
Total Debt$2.0B↑1%$2.0B↑1%$2.5B↑27%$2.0B$2.0B↓3%$2.0B↓1%$2.0B↓14%$2.4B↑5%$2.3B
Shareholders' Equity$354.6M↓25%$354.6M↓25%$395.1M↓21%$403.4M↓21%$452.9M↓14%$524.8M↓37%$835.5M↓4%$868.2M↓6%$920.3M
Current Ratio2.84↓11%2.84↓11%1.62↓45%2.99↓10%3.32↑1%3.30↑8%3.06↓18%3.75↑10%3.42
Debt / Equity5.75↑34%5.75↑34%6.38↑61%4.97↑27%4.31↑12%3.85↑57%2.45↓11%2.75↑12%2.46
Operating Cash Flow$125.0M↑45%-$28.5M↑56%$34.4M↑93%$23.6M↓55%$101.4M↓23%$130.9M↓47%$247.8M↑4055%$6.0M↓94%$93.9M
Free Cash Flow$99.5M↑82%-$35.2M↑50%$28.2M↑147%$18.7M↓56%$70.7M↓32%$103.7M↓53%$222.1M↑1460%-$16.3M↓132%$50.3M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Food Products

BGS vs Peers — Financial Grading

Revenue$1.8BBottom 25%
Net Income$43.3MBottom 25%
ROE-9.6%Bottom 25%
D/E4.31Bottom 25%
Op. Margin5.3%Median
Curr. Ratio3.32Top 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
Mondelez International, Inc.MDLZ$85.5B$67.54$38.5B$2.5B9.5%0.729.2%0.592/93/93/70/3F-Score 64/11
Archer-Daniels-Midland CoADM$34.7B$72.90$80.3B$1.1B4.7%0.33—1.375/92/91/70/3F-Score 55/11
TYSON FOODS, INC.TSN$20.7B$58.82$54.4B$474.0M2.6%0.492.0%1.553/92/90/70/3F-Score 53/11
GENERAL MILLS INCGIS$18.4B$34.32$18.4B$87.6M-1.2%1.834.8%0.683/94/90/71/3F-Score 52/11
HORMEL FOODS CORP /DE/HRL$12.2B$22.09$12.1B$478.2M6.1%0.365.9%2.473/93/92/70/3F-Score 54/11
Lamb Weston Holdings, Inc.LW$7.7B$56.06$6.6B$290.0M15.9%2.018.9%1.422/94/90/70/3F-Score 73/11
SMITHFIELD FOODS INCSFD$7.6B$19.19$15.5B$987.0M14.5%0.298.3%2.976/93/93/73/3F-Score 68/11
CONAGRA BRANDS INC.CAG$7.0B$14.73$11.3B$1.9B-30.1%1.14-14.4%0.903/90/91/70/3F-Score 44/11